X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (265) 265
Publication (30) 30
Book Review (9) 9
Book Chapter (4) 4
Newsletter (4) 4
Conference Proceeding (3) 3
Newspaper Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bosutinib (267) 267
index medicus (136) 136
dasatinib (127) 127
humans (119) 119
imatinib (112) 112
nilotinib (98) 98
chronic myeloid leukemia (91) 91
oncology (90) 90
tyrosine kinase inhibitors (62) 62
chronic myelogenous leukemia (60) 60
hematology (56) 56
leukemia (54) 54
tyrosine kinase inhibitor (54) 54
chronic myeloid-leukemia (53) 53
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (53) 53
protein kinase inhibitors - therapeutic use (51) 51
female (49) 49
antineoplastic agents - therapeutic use (47) 47
male (46) 46
ponatinib (42) 42
pharmacology & pharmacy (38) 38
cancer (37) 37
middle aged (37) 37
tyrosine (36) 36
adult (35) 35
src (33) 33
animals (32) 32
hemic and lymphatic diseases (32) 32
protein kinase inhibitors - pharmacology (32) 32
imatinib mesylate (31) 31
resistance (31) 31
ski-606 (30) 30
aniline compounds - therapeutic use (29) 29
bcr-abl (29) 29
follow-up (29) 29
nitriles - therapeutic use (29) 29
quinolines - therapeutic use (29) 29
safety (28) 28
aniline compounds - adverse effects (26) 26
nitriles - adverse effects (26) 26
quinolines - adverse effects (26) 26
research (26) 26
chronic-phase (25) 25
kinases (25) 25
protein kinase inhibitors - adverse effects (25) 25
quinolines - pharmacology (25) 25
aniline compounds - pharmacology (24) 24
cml (24) 24
nitriles - pharmacology (24) 24
analysis (23) 23
drug therapy (23) 23
protein-tyrosine kinases - antagonists & inhibitors (23) 23
pyrimidines - therapeutic use (23) 23
aged (22) 22
antineoplastic agents - pharmacology (22) 22
care and treatment (22) 22
medicine & public health (22) 22
treatment outcome (22) 22
antineoplastic agents - adverse effects (21) 21
in-vitro (21) 21
young adult (21) 21
aniline compounds - administration & dosage (20) 20
mutation (20) 20
nitriles - administration & dosage (20) 20
protein kinase inhibitors - administration & dosage (20) 20
quinolines - administration & dosage (20) 20
src-family kinases - antagonists & inhibitors (20) 20
therapy (20) 20
dosage and administration (19) 19
pharmacokinetics (19) 19
antineoplastic agents - administration & dosage (18) 18
article (18) 18
hematology, oncology and palliative medicine (18) 18
piperazines - therapeutic use (18) 18
aged, 80 and over (17) 17
cells (17) 17
efficacy (17) 17
mice (17) 17
patients (17) 17
aniline compounds - pharmacokinetics (16) 16
benzamides (16) 16
clinical trials as topic (16) 16
drug resistance, neoplasm (16) 16
kinase inhibitor (16) 16
nitriles - pharmacokinetics (16) 16
philadelphia chromosome (16) 16
quinolines - pharmacokinetics (16) 16
chromosome-positive leukemias (15) 15
cytogenetic responses (15) 15
fusion proteins, bcr-abl - genetics (15) 15
intolerance (15) 15
review (15) 15
adolescent (14) 14
fusion proteins, bcr-abl - antagonists & inhibitors (14) 14
tyrosine kinase (14) 14
cell line, tumor (13) 13
inhibitor (13) 13
leukemia, myeloid, chronic-phase - drug therapy (13) 13
activation (12) 12
health aspects (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (264) 264
French (3) 3
Polish (2) 2
Russian (2) 2
Czech (1) 1
Japanese (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Heterocycles, ISSN 0385-5414, 2016, Volume 92, Issue 10, pp. 1882 - 1887
New and improved synthetic route of tivozanib is described on a hectogram scale. An reduction cyclization process to prepare the key intermediate... 
CHEMISTRY, ORGANIC | KINASE INHIBITORS | BOSUTINIB
Journal Article
Neuroscience, ISSN 0306-4522, 2015, Volume 304, pp. 316 - 327
Highlights • Pre-plaque changes of systemic inflammatory markers. • Early communication between brain and blood immunity. • TKIs in early pre-plaque Aβ stages... 
Neurology | plaque | inflammation | nilotinib | CX3CL1 | bosutinib
Journal Article
Stroke, ISSN 0039-2499, 11/2017, Volume 48, Issue 11, pp. 3108 - 3116
Journal Article
Nature reviews. Drug discovery, ISSN 1474-1776, 07/2017, Volume 16, Issue 8, p. 530
Journal Article
Leukemia Research, ISSN 0145-2126, 03/2019, Volume 78, pp. 36 - 44
In chronic myeloid leukemia (CML), resistance against second-generation tyrosine kinase inhibitors (TKI) remains a serious clinical challenge, especially in... 
BCR-ABL1 T315I | Drug combinations | Drug resistance | Bosutinib
Journal Article
Leukemia Research, ISSN 0145-2126, 03/2019, Volume 78, pp. 36 - 44
In chronic myeloid leukemia (CML), resistance against second-generation tyrosine kinase inhibitors (TKI) remains a serious clinical challenge, especially in... 
BCR-ABL1 T315I | Drug combinations | Drug resistance | Bosutinib
Journal Article
Cancers, ISSN 2072-6694, 09/2019, Volume 11, Issue 10, p. 1414
Breast cancer recurs in 20% of patients following intended curative resection. In vitro data indicates that amide local anaesthetics, including lidocaine,... 
metastasis | Src | cancer recurrence | local anaesthetics | lidocaine | anaesthesia | bosutinib
Journal Article
Heterocycles, ISSN 0385-5414, 2014, Volume 89, Issue 8, pp. 1885 - 1891
New and improved synthetic route of bosutinib intermediate 7-(3-chloropropoxy)-6-methoxy-4-oxo-1,4-dihydroquinoline-3-carbonitrile (3) is described on a... 
Bosutinib Intermediate | Intramolecular Cyclization | New Synthetic Process | BOSUTINIB | IMATINIB | CHEMISTRY, ORGANIC | SKI-606 | KINASE INHIBITOR
Journal Article
Recent Results in Cancer Research, ISSN 0080-0015, 2018, Volume 212, pp. 87 - 108
Bosutinib is one of the five tyrosine kinase inhibitors which are currently approved for the treatment of chronic myeloid leukemia. By its dual inhibition of... 
CML | Keywords | Tyrosine kinase inhibitor | Bosutinib
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2019, Volume 129, Issue 3, p. 1167
Local flow patterns determine the uneven distribution of atherosclerotic lesions. This research aims to elucidate the mechanism of regulation of nuclear... 
Protein tyrosine kinase | Phosphorylation | Transcription factors | Research | Translocation (Genetics) | Endothelium | Nilotinib | Tyrosine | Atherosclerosis | Development and progression | Bosutinib | Integrins
Journal Article
Acta Haematologica Polonica, ISSN 0001-5814, 10/2017, Volume 48, Issue 4, pp. 274 - 281
Tyrosine kinases inhibitors (TKIs) are the mainstay of chronic myeloid leukemia (CML) treatment. The choice of a specific TKI depends on its side effects,... 
Myelogenous | Chronic | Bosutinib | Leukemia | BCR-ABL Positive
Journal Article
Acta Haematologica Polonica, ISSN 0001-5814, 10/2017, Volume 48, Issue 4, pp. 274 - 281
Tyrosine kinases inhibitors (TKIs) are the mainstay of chronic myeloid leukemia (CML) treatment. The choice of a specific TKI depends on its side effects,... 
Myelogenous | Chronic | Leukemia | Bosutinib | BCR-ABL Positive
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 09/2019, Volume 35, Issue 9, pp. 1615 - 1622
Objective: In clinical trials of second-line therapies for chronic phase chronic myeloid leukemia (CP-CML), to date, only single-arm trials have been conducted... 
chronic-phase | dasatinib | Chronic myeloid leukemia | nilotinib | bosutinib | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018, Volume 41, Issue 2, pp. 254 - 258
Ponatinib, a novel tyrosine kinase inhibitor marketed in 2016, is a key drug used for treating chronic myeloid leukemia and Philadelphia chromosome-positive... 
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018
Ponatinib, a novel tyrosine kinase inhibitor marketed in 2016, is a key drug used for treating chronic myeloid leukemia and Philadelphia chromosome-positive... 
high-performance liquid chromatography equipped with ultraviolet detection method | human plasma concentration | ponatinib | bosutinib
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.